M

META Medical Research Institute | Dayton, OH

Research site
(Unclaimed)
Location
1010 Woodman Drive, Suite 210, Dayton, Ohio, United States of America

Site insights

Top conditions

Top treatments

LY3526318
LY3556050
LY3857210
ABP-450
SEL-212
SB-01
VX-548
ETX-018810
Mirikizumab
BHV-3000

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 27 total trials

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain (CPMP)

The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-s...

Enrolling
Chronic Low-back Pain
Diabetic Neuropathic Pain
Drug: LY3016859 ISA
Drug: Placebo Oral

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis...

Active, not recruiting
Ulcerative Colitis
Drug: Mirikizumab
Drug: Placebo

This is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and sa...

Enrolling
Post Surgical Neuropathic Pain
Drug: capsaicin 0.04% topical system
Drug: Qutenza (capsaicin) 8% topical system

The purpose of the clinical trial is to learn whether electrical nerve block via the Altius System is a safe and effective treatment for patients wit...

Active, not recruiting
Residual Limb Pain
Phantom Limb Pain
Device: Altius

The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.

Enrolling
Painful Lumbosacral Radiculopathy
Drug: VX-548
Drug: Placebo

This Phase 2 Extension trial will evaluate the efficacy and safety of ABP-450 for migraine prevention in adults who suffer from six or more migraine...

Invitation-only
Migraine
Drug: ABP-450

This Phase 2 trial will evaluate the efficacy and safety of ABP-450 for migraine prevention in adults who suffer from six or more migraine days per m...

Active, not recruiting
Migraine
Drug: ABP-450
Drug: Placebo

The purpose of the study is to confirm the safety and effectiveness of SB-01 For Injection in adult patients with chronic low back pain and related d...

Enrolling
Lumbar Degenerative Disc Disease
Drug: SB-01 For Injection
Drug: Sham Needle

Trial sponsors

Lilly logo
A
Exact Sciences Corporation logo
Allergan logo
A
E
G
N
Pfizer logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems